Ami Organics Limited IPO: Date, Price, GMP, Review & Essential Details

Firstly Ami Organics Limited affords to its home and worldwide clients the subsequent commitments. Ami Organics Limited is devoted to efficaciously assemble your expectancies of a varied product range.

Secondly Ami Group has the aim of converting affordable cash into speciality chemical substances for Agrochemicals, Cosmetics, and Polymers.

At last Ami Organics Limited employs professional and devoted employees those who run the centres supported via way of means of superior and modern equipment.

They have extended to offer New Chemical Entity (NCE) in addition to huge-scale shipping of pharmaceutical intermediates. Fine and strong point chemical substances that meet ISO requirements. In order to set up the role with inside the international market.

Objectives:

Repayment or prepayment of certain financial centres of the company.
General company purposes.
Funding work for capital necessities of the Company.

Proceeds from the fresh issue could be used toward compensation of resolving debt and investment capital necessities.

The IPO of Ami Organics accommodates the fresh issue of equity stocks really well worth Rs 200 crore and an offer for sale of as much as 6,059,600 equity stocks via way of means of present shareholders.

The enterprise has decreased its fresh issue size to Rs 200 crore from Rs 300 crore after elevating Rs 100 crore in a pre-IPO placement. The price band has been set at Rs 603-610 percentage for the general public issue. At the upper end of the price band, the initial percentage sale is anticipated to fetch Rs 569.63 crore.

Earlier Ami Organics had filed initial papers with SEBI in 2018 and had acquired the regulator's nod to release the general public issue. However, it did not float the IPO. This is the enterprise's second try to issue the public offer.

Half of the issue size has been reserved for qualified institutional investors, 35 per cent for retail investors and the last 15 per cent for non-institutional investors.

IPO Details:

Ami Organics IPO details Subscription Dates1 – 3 September 2021Price BandINR603 – 610 per share Fresh issueINR200 crore Offer For Sale6,059,600 shares (INR365.39 – 369.64 crore)Total IPO sizeINR565.39 – 569.64 crore Minimum bid (lot size)24 shares Face Value INR10 per share Retail Allocation35%Listing On NSE, BSE

Financial Highlights

The company had consistent revenue growth in the last 3 years. Revenues of the company have grown at a CAGR of 12% from Rs 239 cr to Rs 342 cr over the period of FY19 to FY21 while we saw much better improvement profits as it grew from Rs 25 cr to Rs 53 Cr at a CAGR of 29%. The profit margins have grown continuously over the years.

Strength

Big geographic footprint and a diverse consumer base with long-time period partnerships
It has a large and diverse product portfolio, subsidized up via way of means of strong R&D
Proficiency in sales and marketing
Stable financial results
Good management team

Risks

Continuing effect of the Covid-19 pandemic on enterprise and its operations is unpredictable.Covid-19 can have a vast effect and it can have an effect on the future too.
Investors need to study threat elements indicated with inside the RHP of the IPO report earlier than making an investment on this IPO.
The company is concerned with strict requirements, some inspections and audits. Any production or management troubles can be a concern to regulatory movement and may harm the enterprise reputation.
Company derive vast part of its sales from the sale of merchandise in different regions and any discount in call for from such merchandise can have an effect on business.
The company is concerned with stringent environmental, and legal guidelines and other requirements.

Recommendation

The Indian API market is estimated to witness a growth rate of over 9.5% while the Indian pharmaceutical market has increased by 7.4% and reached around $19 billion in FY17 and is expected to reach nearly $29 billion in FY22 on the back of Increasing Incidences of Chronic Diseases. IPO is priced at a PE of 35x on the EPS of Rs. 17.14 which is lower as compared to its peers average. We saw that a few recent IPOs have not performed well in the last couple of months as the market is being choppy. Thus we assign a "Subscribe" rating to the IPO for Mid to Long Term Investors. To invest in Ami Organics Limited IPO, open your demat account and start your investment journey.

DISCLAIMER:

^{The information contained herein are strictly confidential and are meant solely for the information of the recipient and shall not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written permission of Swastika Investmart Ltd. (“SIL”). The contents of this document are for information purpose only. This document is not an investment advice and must not alone be taken as the basis for an investment decision. Before taking any decision to invest, the recipient of this document must read carefully the Red Herring Prospectus (“RHP”) issued to know the details of IPO and various risks and uncertainties associated with the investment in the IPO of the Company. All recipients of this document must before acting on the given information/details, make their own investigation and apply independent judgment based on their specific investment objectives and financial position. They can also seek appropriate professional advice from their own legal and tax consultants, advisors, etc. to understand the risks and investment considerations arising from such investment. The investor should possess appropriate resources to analyze such investment and the suitability of such investment to such investor’s particular circumstances before making any decisions on the investment. The Investor shall be solely responsible for any action taken based on this document. SIL shall not be liable for any direct or indirect losses arising from the use of the information contained in this document and accept no responsibility for statements made otherwise issued or any other source of information received by the investor and the investor would be doing so at his/her/its own risk. The information contained in this document should not be construed as forecast or promise or guarantee or assurance of any kind. The investors are not being offered any assurance or guaranteed or fixed returns on their investments. The users of this document must bear in mind that past performances if any, are not indicative of future results. The actual returns on investment may be materially different than the past. Investments in Securities market products and instruments including in the IPO of the Company are highly risky and they are generally not an appropriate avenue for someone with limited resources/ limited investment and low risk tolerance. Such Investments are subject to market risks including, without limitation, price, volatility and liquidity and capital risks. Therefore, the users of this document must carefully consider all the information given in the RHP including the risks factors before making any investment in the Equity Shares of the Company.Swastika Investmart Ltd or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither Swastika Investmart Ltd nor Research Analysts have any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. Swastika Investment Ltd may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. Research entity has not been engaged in market making activity for the subject company. Research analyst has not served as an officer, director or employee of the subject company. We have not received any compensation/benefits from the Subject Company or third party in connection with the Research Report.CORPORATE & ADMINISTRATIVE OFFICE - 48, Jaora Compound, M.Y.H. Road, Indore - 452 001 | Phone 0731 - 6644000Compliance Officer: Ms. Sheetal Duraphe Email: compliance@swastika.co.in Phone: (0731) 6644 241Swastika Investmart Limited, SEBI Reg. No. : NSE/BSE/MSEI: INZ000192732 Merchant Banking: INM000012102 Investment Adviser: INA000009843 MCX/NCDEX: INZ000072532 CDSL/NSDL: IN-DP-115-2015 RBI Reg. No.: B-03-00174 IRDA Reg. No.: 713.}

Step : 1

Step : 2

Step : 3

Step : 1

Step : 2

Step : 3

SUB - BROKER
DASHBOARD

KYC
DASHBOARD

DOWNLOAD DEALER
SOFTWARE

WEB TRADING

MOBILE TRADING

BACKOFFICE REPORTS

MAIL

KYC DASHBOARD

CRM

BRANCH
BACKOFFICE

SWASTIKA PEOPLE

DOWNLOAD s

Ami Organics Limited IPO